| Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma AH Nassar, S Abou Alaiwi, SH AlDubayan, N Moore, KW Mouw, ... Genetics in Medicine 22 (4), 709-718, 2020 | 62 | 2020 |
| Detection of pathogenic variants with germline genetic testing using deep learning vs standard methods in patients with prostate cancer and melanoma SH AlDubayan, JR Conway, SY Camp, L Witkowski, E Kofman, ... Jama 324 (19), 1957-1969, 2020 | 39 | 2020 |
| Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections H Chung, C Merakou, MM Schaefers, KB Flett, S Martini, R Lu, ... Nature Communications 13 (1), 1231, 2022 | 30 | 2022 |
| The combined treatment of amyloid-β1-42-stimulated bone marrow–derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in … F Wang, H Liu, X Shen, H Ao, N Moore, L Gao, L Chen, H Hu, H Ma, ... Neurobiology of Aging 36 (1), 111-122, 2015 | 22 | 2015 |
| Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology B Reardon, ND Moore, NS Moore, E Kofman, SH AlDubayan, ... Nature cancer 2 (10), 1102-1112, 2021 | 19 | 2021 |
| Bladder cancer radiation oncology of the future: prognostic modelling, radiomics, and treatment planning with artificial intelligence NS Moore, A McWilliam, S Aneja Seminars in Radiation Oncology 33 (1), 70-75, 2023 | 8 | 2023 |
| Integrative Analysis of Germline Rare Variants in Clear and Non–clear Cell Renal Cell Carcinoma SH Han, SY Camp, H Chu, R Collins, R Gillani, J Park, Z Bakouny, ... European Urology Open Science 62, 107-122, 2024 | 4 | 2024 |
| Inherited DNA repair and cell cycle gene defects in chronic lymphocytic leukemia. NS Moore, SH Aldubayan, A Taylor-Weiner, S Stilgenbauer, G Getz, ... Journal of Clinical Oncology 37 (15_suppl), 1508, 2019 | 4 | 2019 |
| Comparison of pulmonary toxicity after total body irradiation-and busulfan-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in pediatric … KX Liu, N Poux, KY Shin, N Moore, YH Chen, S Margossian, JS Whangbo, ... Transplantation and cellular therapy 28 (8), 502. e1-502. e12, 2022 | 2 | 2022 |
| Clinical interpretation of integrative molecular profiles to guide precision cancer medicine B Reardon, ND Moore, N Moore, E Kofman, S Aldubayan, A Cheung, ... bioRxiv, 2020.09. 22.308833, 2020 | 2 | 2020 |
| Inherited DNA repair and cell cycle gene defects in chronic lymphocytic leukemia BJR Moore NS, AlDubayan SH, Taylor-Weiner A, Stilgenbauer S, Getz G., Wu CJ ... HemaSphere 3, 512-513, 2019 | 2* | 2019 |
| Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy N Verma, JH Laird, NS Moore, TJ Hayman, N Housri, GW Peters, ... Advances in Radiation Oncology 9 (6), 101500, 2024 | 1 | 2024 |
| Applying Language Models to Radiology Text for Identifying Oligometastatic Non-Small Cell Lung Cancer NS Moore, JH Laird, N Verma, T Hager, D Sritharan, V Lee, R Maresca, ... International Journal of Radiation Oncology, Biology, Physics 120 (2), e644, 2024 | | 2024 |
| Lymph node metastasis prediction with non-small cell lung cancer histopathology imaging. V Lee, ALO King, D Sritharan, NS Moore, S Chadha, R Maresca, T Hager, ... Journal of Clinical Oncology 42 (16_suppl), 8063-8063, 2024 | | 2024 |
| Abstract P01: Impact of Germline and Somatic ATM Variants in Chronic Lymphocytic Leukemia (CLL): Clinical Implications and Response to PARP Inhibition K Mashima, N Moore, M Mikhaleva, A Petráčková, S Shupe, ... Blood Cancer Discovery 5 (2_Supplement), P01-P01, 2024 | | 2024 |
| Characteristics of Rare Germline ATM Variants in Chronic Lymphocytic Leukemia (CLL) K Mashima, BL Lampson, A Gupta, N Moore, A Petrackova, SJ Shupe, ... Blood 140 (Supplement 1), 9853-9854, 2022 | | 2022 |
| Predictors of Early Polymetastasis after Comprehensive Local Therapy for Synchronous Oligometastatic NSCLC JH Laird Jr, N Verma, NS Moore, HSM Park, S Aneja International Journal of Radiation Oncology, Biology, Physics 114 (3), S32, 2022 | | 2022 |
| Radioresistant Lung Oligometastases: Impact of Histology and Dose on Local Control N Verma, JH Laird, NS Moore, HSM Park International Journal of Radiation Oncology, Biology, Physics 114 (3), e407, 2022 | | 2022 |
| Oligometastatic Tumor Size as a Predictor of Distant Failure in Synchronous Oligometastatic NSCLC NS Moore, J Laird, N Verma, HSM Park International Journal of Radiation Oncology, Biology, Physics 114 (3), e406, 2022 | | 2022 |
| PULMONARY TOXICITY AFTER TOTAL BODY IRRADIATION-BASED AND BUSULFAN-BASED MYELOABLATIVE CONDITIONING FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PEDIATRIC AND … KX Liu, N Poux, N Moore, S Margossian, JS Whangbo, CN Duncan, ... PEDIATRIC BLOOD & CANCER 68, S189-S190, 2021 | | 2021 |
